Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-06-23

Clinical Trial Update: Novel Peptide Vaccination for Patients With Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Ongoing early-phase clinical trial updates on a novel peptide vaccination for advanced prostate cancer, spanning Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel Peptide Vaccination

Snippet

Sponsor: Iwate Medical University | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN